Centro de Referencia E Treinamento Dst/Aids
Sao Paulo, Brazil
Hospital in São Paulo, State of São Paulo
R. Santa Cruz, 81 - Vila Mariana, São Paulo - SP, 04121-000
About Centro de Referencia E Treinamento Dst/Aids
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centro de Referencia E Treinamento Dst/Aids
During the past decade, Centro de Referencia E Treinamento Dst/Aids conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
1999-10-01
2012-11-01
Completed
354
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
2001-07-01
2008-05-01
Completed
69
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro de Referencia E Treinamento Dst/Aids" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials
sponsored, "Gilead Sciences" with 1 trials sponsored, "Oswaldo Cruz Foundation" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Referencia E Treinamento Dst/Aids"
#1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centro de Referência e Treinamento DST AIDS" with 1 trials as a collaborator and "Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Centro de Referencia E Treinamento Dst/Aids
According to Clinical.Site data, the most researched conditions in "Centro de Referencia E Treinamento Dst/Aids" are
"HIV Infections" (4 trials), "AIDS" (1 trials), "COVID-19 Prevention" (1 trials), "HIV" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Centro de Referencia E Treinamento Dst/Aids" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Referencia E Treinamento Dst/Aids
Most popular intervention types in "Centro de Referencia E Treinamento Dst/Aids" are "Biological" (7 trials), "Drug" (5 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ad26.COV2.S" (3 trials), "Placebo" (3 trials), "Ad26.Mos4.HIV" (1 trials), "All licensed antiretroviral medications" (1 trials) and "Clade C and Mosaic gp140 HIV bivalent vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Referencia E Treinamento Dst/Aids
The vast majority of trials in "Centro de Referencia E Treinamento Dst/Aids" are
12 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centro de Referencia E Treinamento Dst/Aids
Currently, there are NaN active trials in "Centro de Referencia E Treinamento Dst/Aids".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Centro de Referencia E Treinamento Dst/Aids,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Referencia E Treinamento Dst/Aids, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".